Robust immune responses after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2 experienced individuals

The use of COVID-19 vaccines will play the major role in helping to end the pandemic that has killed millions worldwide. COVID-19 vaccines have resulted in robust humoral responses and protective efficacy in human trials, but efficacy trials excluded individuals with a prior diagnosis of COVID-19. A...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:medRxiv
Asıl Yazarlar: Samanovic, Marie I., Cornelius, Amber R., Gray-Gaillard, Sophie L., Allen, Joseph Richard, Karmacharya, Trishala, Wilson, Jimmy P., Hyman, Sara Wesley, Tuen, Michael, Koralov, Sergei B., Mulligan, Mark J., Herati, Ramin Sedaghat
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Cold Spring Harbor Laboratory 2021
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7885942/
https://ncbi.nlm.nih.gov/pubmed/33594383
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2021.02.07.21251311
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller